Cargando…
Chemogenomic Screen for Imipenem Resistance in Gram-Negative Bacteria
Carbapenem-resistant Gram-negative bacteria are considered a major threat to global health. Imipenem (IMP) is used as a last line of treatment against these pathogens, but its efficacy is diminished by the emergence of resistance. We applied a whole-genome screen in Escherichia coli, Klebsiella pneu...
Autores principales: | El Khoury, Jessica Y., Maure, Alexandra, Gingras, Hélène, Leprohon, Philippe, Ouellette, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6867876/ https://www.ncbi.nlm.nih.gov/pubmed/31744905 http://dx.doi.org/10.1128/mSystems.00465-19 |
Ejemplares similares
-
Azithromycin resistance mutations in Streptococcus pneumoniae as revealed by a chemogenomic screen
por: Gingras, Hélène, et al.
Publicado: (2020) -
Delving in folate metabolism in the parasite Leishmania major through a chemogenomic screen and methotrexate selection
por: Bigot, Sophia, et al.
Publicado: (2023) -
Imipenem Resistance among Gram-Negative and Gram-Positive Bacteria in Hospitalized Patients
por: Khorshidi, A, et al.
Publicado: (2010) -
Coupling next-generation sequencing to dominant positive screens for finding antibiotic cellular targets and resistance mechanisms in Escherichia coli
por: Gingras, Hélène, et al.
Publicado: (2018) -
Corrigendum: Coupling next-generation sequencing to dominant positive screens for finding antibiotic cellular targets and resistance mechanisms in Escherichia coli
por: Gingras, Hélène, et al.
Publicado: (2022)